446 related articles for article (PubMed ID: 25987178)
41. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
[TBL] [Abstract][Full Text] [Related]
42. Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy.
Sevin C; Benraiss A; Van Dam D; Bonnin D; Nagels G; Verot L; Laurendeau I; Vidaud M; Gieselmann V; Vanier M; De Deyn PP; Aubourg P; Cartier N
Hum Mol Genet; 2006 Jan; 15(1):53-64. PubMed ID: 16311251
[TBL] [Abstract][Full Text] [Related]
43. Safety of arylsulfatase A overexpression for gene therapy of metachromatic leukodystrophy.
Capotondo A; Cesani M; Pepe S; Fasano S; Gregori S; Tononi L; Venneri MA; Brambilla R; Quattrini A; Ballabio A; Cosma MP; Naldini L; Biffi A
Hum Gene Ther; 2007 Sep; 18(9):821-36. PubMed ID: 17845130
[TBL] [Abstract][Full Text] [Related]
44. Genetics of metachromatic leukodystrophy.
Gieselmann V; Kreysing J; von Figura K
Gene Ther; 1994; 1 Suppl 1():S87. PubMed ID: 8542433
[TBL] [Abstract][Full Text] [Related]
45. Gene therapy for metachromatic leukodystrophy.
Rosenberg JB; Kaminsky SM; Aubourg P; Crystal RG; Sondhi D
J Neurosci Res; 2016 Nov; 94(11):1169-79. PubMed ID: 27638601
[TBL] [Abstract][Full Text] [Related]
46. Leukodystrophy presenting as acute-onset polyradiculoneuropathy.
Dubey R; Chakrabarty B; Gulati S; Sharma MC; Deopujari S; Baheti N; Santosh V; Pai G; Kabra M
Pediatr Neurol; 2014 Jun; 50(6):616-8. PubMed ID: 24685010
[TBL] [Abstract][Full Text] [Related]
47. Metachromatic leukodystrophy: a comparative study of the ultrastructural findings in the peripheral nervous system of three cases, one of the late infantile, one of the juvenile and one of the adult form of the disease.
Luijten JA; Straks W; Blikkendaal-Lieftinck LF; Staal GE; Willemse J
Neuropadiatrie; 1978 Nov; 9(4):338-50. PubMed ID: 218147
[TBL] [Abstract][Full Text] [Related]
48. White matter dysfunction and its neuropsychological correlates: a longitudinal study of a case of metachromatic leukodystrophy treated with bone marrow transplant.
Shapiro EG; Lipton ME; Krivit W
J Clin Exp Neuropsychol; 1992 Jul; 14(4):610-24. PubMed ID: 1356997
[TBL] [Abstract][Full Text] [Related]
49. Investigations of micro-organic brain damage (MOBD) in heterozygotes of metachromatic leukodystrophy.
Tylki-Szymańska A; Ługowska A; Chmielik J; Kotowicz J; Jakubowska-Winecka A; Zobel M; Berger J; Molzer B
Am J Med Genet; 2002 Jul; 110(4):315-9. PubMed ID: 12116203
[TBL] [Abstract][Full Text] [Related]
50. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
[TBL] [Abstract][Full Text] [Related]
51. Sixteen novel mutations in the arylsulfatase A gene causing metachromatic leukodystrophy.
Luzi P; Rafi MA; Rao HZ; Wenger DA
Gene; 2013 Nov; 530(2):323-8. PubMed ID: 24001781
[TBL] [Abstract][Full Text] [Related]
52. Novel candidate disease for gene therapy: metachromatic leukodystrophy.
Biffi A; Naldini L
Expert Opin Biol Ther; 2007 Aug; 7(8):1193-205. PubMed ID: 17696818
[TBL] [Abstract][Full Text] [Related]
53. Allogeneic hematopoietic cell transplantation for adult metachromatic leukodystrophy: a case series.
Riedel A; Faul C; Reuss K; Schröder JC; Lang PJ; Lengerke C; Weissert N; Hengel H; Gröschel S; Schoels L; Bethge WA
Blood Adv; 2024 Mar; 8(6):1504-1508. PubMed ID: 38330194
[TBL] [Abstract][Full Text] [Related]
54. Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers.
Harrington M; Whalley D; Twiss J; Rushton R; Martin S; Huynh L; Yang H
Orphanet J Rare Dis; 2019 Apr; 14(1):89. PubMed ID: 31036045
[TBL] [Abstract][Full Text] [Related]
55. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.
Boucher AA; Miller W; Shanley R; Ziegler R; Lund T; Raymond G; Orchard PJ
Orphanet J Rare Dis; 2015 Aug; 10():94. PubMed ID: 26245762
[TBL] [Abstract][Full Text] [Related]
56. Metachromatic leukodystrophy presenting as bipolar disorder.
Velakoulis D; Ting A; Winton-Brown T; Walterfang M; Gaillard F
Aust N Z J Psychiatry; 2014 Dec; 48(12):1171-2. PubMed ID: 25237139
[No Abstract] [Full Text] [Related]
57. Blood to brain to the rescue.
Proia RL; Wu YP
J Clin Invest; 2004 Apr; 113(8):1108-10. PubMed ID: 15085187
[TBL] [Abstract][Full Text] [Related]
58. Haematopoietic stem cell transplantation does not retard disease progression in the psycho-cognitive variant of late-onset metachromatic leukodystrophy.
Smith NJ; Marcus RE; Sahakian BJ; Kapur N; Cox TM
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S471-5. PubMed ID: 21080229
[TBL] [Abstract][Full Text] [Related]
59. Slow progression of juvenile metachromatic leukodystrophy 6 years after bone marrow transplantation.
Kapaun P; Dittmann RW; Granitzny B; Eickhoff W; Wulbrand H; Neumaier-Probst E; Zander A; Kohlschüetter A
J Child Neurol; 1999 Apr; 14(4):222-8. PubMed ID: 10334395
[TBL] [Abstract][Full Text] [Related]
60. Late juvenile metachromatic leukodystrophy treated with bone marrow transplantation; a 4-year follow-up study.
Navarro C; Fernández JM; Domínguez C; Fachal C; Alvarez M
Neurology; 1996 Jan; 46(1):254-6. PubMed ID: 8559389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
